All In MedTech

Device Trial Radar · NCT03632447

Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence

A Prospective Randomized Efficacy Study Comparing a Pelvic Digital Health System Home Program of Pelvic Floor Muscle Exercise to Kegel Exercises in the Treatment of Stress-Predominant Urinary Incontinence

Last checked: Nov 19, 2026Latest source record: Oct 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

77

Actual

Start

Oct 24, 2018

Primary completion

Aug 1, 2019

Study completion Oct 1, 2019

Sponsor

Lead sponsor
Renovia, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 15, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized controlled trial for patients with stress urinary incontinence or stress-dominant mixed incontinence. Subjects will be randomized to 8-weeks of home kegel exercises or 8 weeks of pelvic floor muscle exercises using the leva digital pelvic health system that includes visual biofeedback via smartphone.

Conditions

  • Stress Urinary Incontinence
  • Mixed Urinary Incontinence

Interventions

  • LevaDevice

    Subjects randomized to Leva will use a vaginal probe containing motion-based sensors to direct the performance of pelvic muscle exercises.

  • PFDxDevice

    All subjects (in both study arms) will be evaluated using a vaginally placed device that will evaluate pelvic floor motion to document change in pelvic floor muscle function resulting from pelvic floor muscle exercises.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PGI-ITime frame: 8 weeks after randomization
  2. UDI-6Time frame: 8 weeks after randomization

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • Cedars-Sinai Medical Group

    Beverly Hills, California

  • Northwestern University

    Chicago, Illinois

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.